Clinical Trial Update: Hymovis™ Versus Placebo in Knee Osteoarthritis [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing Hymovis to placebo for knee osteoarthritis has completed enrollment/status; results are not provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Hymovis (hyaluronic acid derivative)

Snippet

Sponsor: Fidia Farmaceutici s.p.a. | Conditions: Knee Osteoarthritis | Phase 3 | Status: COMPLETED